Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.
Saved in:
| Title: | Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis. |
|---|---|
| Authors: | James LP; PhD Program in Health Policy, Harvard University, Cambridge, Massachusetts, United States of America.; Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America., Klaassen F; Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America., Sweeney S; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom., Furin J; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America., Franke MF; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America., Yaesoubi R; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, United States of America., Chesov D; Discipline of Pneumology and Allergology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chişinǎu, Moldova.; Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany., Ciobanu N; Chiril Draganiuc Institute of Phthisiopneumology, Chișinǎu, Moldova., Codreanu A; Chiril Draganiuc Institute of Phthisiopneumology, Chișinǎu, Moldova., Crudu V; Chiril Draganiuc Institute of Phthisiopneumology, Chișinǎu, Moldova., Cohen T; Department of Epidemiology and Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America., Menzies NA; Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America. |
| Source: | PLoS medicine [PLoS Med] 2024 May 03; Vol. 21 (5), pp. e1004401. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38701084 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22James+LP%22">James LP</searchLink>; PhD Program in Health Policy, Harvard University, Cambridge, Massachusetts, United States of America.; Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Klaassen+F%22">Klaassen F</searchLink>; Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Sweeney+S%22">Sweeney S</searchLink>; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Furin+J%22">Furin J</searchLink>; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Franke+MF%22">Franke MF</searchLink>; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Yaesoubi+R%22">Yaesoubi R</searchLink>; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, United States of America.<br /><searchLink fieldCode="AU" term="%22Chesov+D%22">Chesov D</searchLink>; Discipline of Pneumology and Allergology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chişinǎu, Moldova.; Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.<br /><searchLink fieldCode="AU" term="%22Ciobanu+N%22">Ciobanu N</searchLink>; Chiril Draganiuc Institute of Phthisiopneumology, Chișinǎu, Moldova.<br /><searchLink fieldCode="AU" term="%22Codreanu+A%22">Codreanu A</searchLink>; Chiril Draganiuc Institute of Phthisiopneumology, Chișinǎu, Moldova.<br /><searchLink fieldCode="AU" term="%22Crudu+V%22">Crudu V</searchLink>; Chiril Draganiuc Institute of Phthisiopneumology, Chișinǎu, Moldova.<br /><searchLink fieldCode="AU" term="%22Cohen+T%22">Cohen T</searchLink>; Department of Epidemiology and Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.<br /><searchLink fieldCode="AU" term="%22Menzies+NA%22">Menzies NA</searchLink>; Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101231360%22">PLoS medicine</searchLink> [PLoS Med] 2024 May 03; Vol. 21 (5), pp. e1004401. <i>Date of Electronic Publication: </i>2024 May 03 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101231360 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-1676 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215491277%22">15491277 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38701084 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pmed.1004401 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1004401 Titles: – TitleFull: Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: James LP – PersonEntity: Name: NameFull: Klaassen F – PersonEntity: Name: NameFull: Sweeney S – PersonEntity: Name: NameFull: Furin J – PersonEntity: Name: NameFull: Franke MF – PersonEntity: Name: NameFull: Yaesoubi R – PersonEntity: Name: NameFull: Chesov D – PersonEntity: Name: NameFull: Ciobanu N – PersonEntity: Name: NameFull: Codreanu A – PersonEntity: Name: NameFull: Crudu V – PersonEntity: Name: NameFull: Cohen T – PersonEntity: Name: NameFull: Menzies NA IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 05 Text: 2024 May 03 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1549-1676 Numbering: – Type: volume Value: 21 – Type: issue Value: 5 Titles: – TitleFull: PLoS medicine Type: main |
| ResultId | 1 |